Ajit Bhatt

Ajit Bhatt specializes in tumor glycoproteomics, developing mass spectrometry-based approaches to map the glycan landscape of cancer cells and identify aberrant glycosylation patterns that serve as diagnostic biomarkers and therapeutic targets. His work has revealed cancer-type-specific N-glycosylation signatures that distinguish malignant from normal tissues with high sensitivity and specificity. He has characterized how altered glycosylation modifies protein function in key oncogenic signaling pathways. His glycoproteomics platforms are advancing clinical glycan biomarker discovery for early cancer detection.